Supplements and Mirabegron.
Mirabegron, sold under the brand name Betmiga, is an antimuscarinic agent for urinary urgency or overactive bladder.
Mirabegron is an antimuscarinic agent for urinary urgency or overactive bladder. The class blocks muscarinic acetylcholine receptors in the detrusor muscle, reducing involuntary contraction. UK prescribing includes solifenacin, tolterodine, oxybutynin, and mirabegron (technically a beta-3 agonist but in the same prescribing space). The supplement surface includes additive anticholinergic burden, which matters most in older patients given the cognitive decline signal that has emerged in long anticholinergic exposure data. Supplements with anticholinergic potential at high doses (some choline pathway compounds in reverse, certain antiemetic herbals) warrant care. Dry mouth. Constipation. Urinary retention. All three scale with dose. The NICE NG123 guideline pushes for review of indication and dose every six to twelve months, given the cognitive burden picture.
We have not yet completed an explicit assessment of supplement interactions with Mirabegron in the Distil database. That is different from saying nothing exists. We surface this distinction deliberately: the Distil checker tells you when we have explicitly assessed a pair and when we have not, because both are useful information. If you take Mirabegron alongside a supplement, the checker below will surface anything already in our database, and the missing-item form at the bottom of the page routes uncatalogued pairs into our next curation pass.
What this list does not say. Pairs not flagged here are not implicitly safe. They are either not yet in our database, or fall outside our inclusion scope (food-supplement interactions only; for drug-drug interactions, the BNF is authoritative). Use the checker below to surface any supplement, and submit a missing item if you take something we have not catalogued.
How we grade severity, choose what's in scope, and what we exclude.
Every call on this page is reasoned. We publish the full rubric for severity tiers, the medication inclusion logic, the evidence grades we accept, and what we deliberately leave out. About three thousand words. Worth reading once if you use this tool more than occasionally.
Read the full methodologyWant this checked across everything you take?
This page checks the pairs you enter. The personalised Distil report goes further:
- the same graded, cited interaction check across your whole stack, not just the pairs you thought to type in
- where your current routine may be leaving you short of your goals
- the evidence-backed compounds worth adding, and the ones worth dropping
It's a paid report: £79, or £49 for the first 25 customers. The interactions check is one section of it, and you can read a real one in full before you buy.
See a real sample reportSomething missing?
If a supplement or medication you take isn't in our autocomplete, tell us. We go through what people flag every week and add what's missing.